Important step towards approval of enhanced glaucoma medication LUMIGAN® (bimatoprost ophthalmic solution) 0.01% in 27 countries within the European Union Amsterdam, The Netherlands, 23 October, 2009 – Allergan Ltd. announced today that the Committee for Medicinal Products for Human Use (CHMP) has recommended granting a Marketing Authorisation for a new version of LUMIGAN® (bimatoprost ophthalmic [...]
Medical technology company Aipermon presents its concept of sophisticated health systems for all ages at the Medica Fair 2009
“Welcome Your Health” – at any age: With this motto medical technology company Aipermon presents its concept of sophisticated health systems for all ages at the Medica Fair 2009. The product lines for activity monitoring and telemonitoring systems are aimed at special needs and requirements for all ages and used by healthcare professionals for the [...]
Patient Monitoring Markets
This report assesses the patient monitoring device market drivers and bottlenecks from the perspective of medical and manufacturer communities; discusses the potential benefits of the patient monitoring device market for various sectors of the medical community; Patient monitoring is vital to care in operating rooms, emergency rooms, intensive care units and critical care units. It [...]
RE-LY: Oral antithrombin dabigatran prevented strokes and peripheral embolic events in patients with atrial fibrillation
An oral anticoagulant that does not go by the name of warfarin prevented strokes and peripheral embolic events in patients with atrial fibrillation (AF) significantly better than that much older drug at a higher dose and just as well at a lower dose in a huge randomized trial [1]. It was also just as safe [...]
No effect of traction in patients with low back pain: a single centre, single blind, randomized controlled trial of Intervertebral Differential Dynamics Therapy®
Abstract Low back pain (LBP) poses a significant problem to society. Although initial conservative therapy may be beneficial, persisting chronic LBP still frequently leads to expensive invasive intervention. A novel non-invasive therapy that focuses on discogenic LBP is Intervertebral Differential Dynamics Therapy® (IDD Therapy, North American Medical Corp. Reg U.S.). IDD Therapy consists of intermittent [...]
Recent Comments